Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Parkinson's Disease

  Free Subscription


1 BMC Neurosci
1 Brain Res
1 Int J Neurosci
1 J Neural Transm (Vienna)
1 J Neurochem
2 J Neurosci
1 Lancet Neurol
5 Mov Disord
1 Neurochem Res
1 Neurosci Lett
1 Neuroscience
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Neurosci

  1. NICCOLINI F, Wilson H, Giordano B, Diamantopoulos K, et al
    Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease.
    BMC Neurosci. 2019;20:55.
    PubMed     Text format     Abstract available

    Brain Res

  2. HILL AT, McModie S, Fung W, Hoy KE, et al
    Impact of Prefrontal Intermittent Theta-Burst Stimulation on Working Memory and Executive Function in Parkinson's Disease: A Double-Blind Sham-Controlled Pilot Study.
    Brain Res. 2019 Oct 18:146506. doi: 10.1016/j.brainres.2019.146506.
    PubMed     Text format     Abstract available

    Int J Neurosci

  3. CEDERBERG KL, Brinkley EB, Belotserkovkaya N, Memon RA, et al
    Does restless legs syndrome impact cognitive function via sleep quality in adults with Parkinson's disease?
    Int J Neurosci. 2019 Oct 25:1-8. doi: 10.1080/00207454.2019.1681423.
    PubMed     Text format     Abstract available

    J Neural Transm (Vienna)

  4. LEE JY, Ahn J, Yoon EJ, Oh S, et al
    Macular ganglion-cell-complex layer thinning and optic nerve integrity in drug-naive Parkinson's disease.
    J Neural Transm (Vienna). 2019 Oct 19. pii: 10.1007/s00702-019-02097.
    PubMed     Text format     Abstract available

    J Neurochem

  5. CORREIA GUEDES L, Mestre T, Outeiro TF, Ferreira JJ, et al
    Are genetic and idiopathic forms of Parkinson's disease the same disease?
    J Neurochem. 2019 Oct 23. doi: 10.1111/jnc.14902.
    PubMed     Text format     Abstract available

    J Neurosci

  6. DE LUZY IR, Niclis JC, Gantner CW, Kauhausen JA, et al
    Isolation of LMX1a ventral midbrain progenitors improves the safety and predictability of human pluripotent stem cell-derived neural transplants in Parkinsonian Disease.
    J Neurosci. 2019 Oct 21. pii: JNEUROSCI.1160-19.2019.
    PubMed     Text format     Abstract available

  7. HYLAND BI, Seeger-Armbruster S, Smither RA, Parr-Brownlie LC, et al
    Altered recruitment of motor cortex neuronal activity during the grasping phase of skilled reaching in a chronic rat model of unilateral Parkinsonism.
    J Neurosci. 2019 Oct 21. pii: JNEUROSCI.0720-19.2019.
    PubMed     Text format     Abstract available

    Lancet Neurol

    Glycolysis as a therapeutic target for Parkinson's disease.
    Lancet Neurol. 2019 Oct 15. pii: S1474-4422(19)30404.
    PubMed     Text format    

    Mov Disord

  9. LI J, Dauer W
    Cholinergic interneurons drive maladaptive changes in thalamostriatal circuitry after dopamine depletion.
    Mov Disord. 2019;34:682.
    PubMed     Text format    

    You shall not pass! Gut bacteria can convert levodopa to dopamine.
    Mov Disord. 2019;34:986.
    PubMed     Text format    

  11. PACHECO-PAEZ T, Montastruc F, Rousseau V, Chebane L, et al
    Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study.
    Mov Disord. 2019 Oct 21. doi: 10.1002/mds.27876.
    PubMed     Text format     Abstract available

  12. PRETEGIANI E, Vanegas-Arroyave N, FitzGibbon EJ, Hallett M, et al
    Evidence From Parkinson's Disease That the Superior Colliculus Couples Action and Perception.
    Mov Disord. 2019 Oct 21. doi: 10.1002/mds.27861.
    PubMed     Text format     Abstract available

  13. HAYAKAWA H, Nakatani R, Ikenaka K, Aguirre C, et al
    Structurally distinct alpha-synuclein fibrils induce robust parkinsonian pathology.
    Mov Disord. 2019 Oct 23. doi: 10.1002/mds.27887.
    PubMed     Text format     Abstract available

    Neurochem Res

  14. ESSA MM, Subash S, Dhanalakshmi C, Manivasagam T, et al
    Correction to: Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2019 Oct 18. pii: 10.1007/s11064-019-02887.
    PubMed     Text format     Abstract available

    Neurosci Lett

  15. FINE JM, Stroebel BM, Faltesek KA, Terai K, et al
    Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.
    Neurosci Lett. 2019;714:134567.
    PubMed     Text format     Abstract available


  16. HOU L, Sun F, Sun W, Zhang L, et al
    Lesion of the locus coeruleus damages learning and memory performance in paraquat and maneb-induced mouse Parkinson's disease model.
    Neuroscience. 2019 Oct 18. pii: S0306-4522(19)30651.
    PubMed     Text format     Abstract available

    PLoS One

  17. ZHU Y, Pu J, Chen Y, Zhang B, et al
    Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.
    PLoS One. 2019;14:e0224236.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.